Para-Toluenesulfonamide

对甲苯磺酰胺

Report date: 2024/02/21 11:58:28
NME

Base Information

Drug NamePara-Toluenesulfonamide
Drug Alias Namep-TosylamidePTS-302p-TSAPTS-02PTS-100 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursAirway ObstructionCarcinoma, Non-Small-Cell Lung +[6] 
Global Approved IndicationsAirway ObstructionCarcinoma, Non-Small-Cell Lung
Approved Indications in ChinaAirway ObstructionCarcinoma, Non-Small-Cell Lung
Original Approved Country/TerritoryMainland China
Original Approved Date2022/11/15
Country/TerritoryUnited StatesTaiwanMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Jiandakang New Drug Development Co LtdGongwin Biopharm Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGongwin Biopharm Co LtdTianjin Hongri Jiandakang Medical Technology Co Ltd
Inactive CompaniesPts International IncBeijing Jiandakang New Drug Development Co Ltd
Active IndicationsAirway ObstructionCarcinoma, Non-Small-Cell LungCarcinoma, Hepatocellular
Inactive IndicationsSolid tumoursLung NeoplasmsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A